Who backs Odyssey Therapeutics?
32 investors| Investor | Type |
|---|---|
| General Catalyst | Venture capital |
| Fidelity Management & Research Company | Asset manager |
| KB Investment | Venture capital |
| Alexandria Venture Investments | Other |
| OrbiMed | Growth equity |
| Balderton Capital | Other |
| Catalio Capital Management | Venture capital |
| T. Rowe Price Group | — |
| Foresite Capital | Venture capital |
| GreatPoint Ventures | Venture capital |
| + 22 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Odyssey Therapeutics investors
32 investors are on record for Odyssey Therapeutics, including General Catalyst, Fidelity Management & Research Company, KB Investment and Alexandria Venture Investments. By type, the record holds 9 venture capital firms and 4 hedge funds. The later-stage round in Jun 2025 drew 55 investors.
Free account
More of Odyssey Therapeutics with a free account
- ·The complete investor list: 32 names
- ·Watch Odyssey Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 32 firms already write checks for companies like Odyssey Therapeutics in biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View